These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38390209)

  • 1. Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomas.
    Zhao ZH; Huang Y; Jiang C; Lv GY; Wang M
    Front Endocrinol (Lausanne); 2024; 15():1326112. PubMed ID: 38390209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms for Predicting Survival Outcomes in Patients with Neuroendocrine Neoplasms of the Gallbladder Undergoing Primary Tumor Resection: A Population-Based Study.
    Zhang YR; Hu GC; Fan MK; Yao HL; Jiang C; Shi HY; Lin R
    Curr Oncol; 2023 Feb; 30(3):2889-2899. PubMed ID: 36975434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.
    Zheng BH; Zhang C; Wan WZ; Sun WT; Cheng X; Ni XJ; Ni XL; Suo T; Liu H; Shen S; Liu HB
    BMC Surg; 2022 Jun; 22(1):253. PubMed ID: 35768809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.
    Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S
    Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis.
    Do MY; Jang SI; Kang HP; Kim EJ; Lee KJ; Park GE; Lee SJ; Lee DK; Woo SM; Cho JH
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary Neuroendocrine Neoplasms: Analysis of Prognostic Factors and Development and Validation of a Nomogram.
    Zhou S; Jiang S; Chen W; Yin H; Dong L; Zhao H; Han S; He X
    Front Oncol; 2021; 11():654439. PubMed ID: 34350109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential and prognostic MRI features of gallbladder neuroendocrine tumors and adenocarcinomas.
    Bae JS; Kim SH; Yoo J; Kim H; Han JK
    Eur Radiol; 2020 May; 30(5):2890-2901. PubMed ID: 32025835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine neoplasms of the gallbladder: early detection and surgery is key to improved outcome.
    Gogna S; Samson D; Gachabayov M; Rojas A; Felsenreich DM; Koo D; Gu K; Quintero L; Miller KR; Azim A; Da Eric Dong X
    Langenbecks Arch Surg; 2022 Feb; 407(1):197-206. PubMed ID: 34236488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prognostic nomogram based on log odds of positive lymph nodes to predict the overall survival in biliary neuroendocrine neoplasms (NENs) patients after surgery.
    Jiang S; Yang F; Zhang L; Sang X; Lu X; Zheng Y; Xu Y
    J Endocrinol Invest; 2022 Dec; 45(12):2341-2351. PubMed ID: 35908009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms.
    Xu R; Zhou B; Hu P; Xue B; Gu D; Li X; Tang Q
    World J Surg Oncol; 2021 Aug; 19(1):233. PubMed ID: 34364382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
    Xie S; Li L; Wang X; Li L
    Medicine (Baltimore); 2021 Jan; 100(2):e24223. PubMed ID: 33466202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma.
    Wang Z; Wang L; Hua Y; Zhuang X; Bai Y; Wang H
    Front Oncol; 2023; 13():1157057. PubMed ID: 37260969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One Decade.
    Wang Y; Huang B; Fu Q; Wang J; Ye M; Hu M; Qu K; Liu K; Hu X; Wei S; Sun K; Xiao W; Zhang B; Li H; Li J; Zhang Q; Liang T
    Ann Surg Oncol; 2022 Nov; 29(12):7619-7630. PubMed ID: 35849293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics analysis and prognostic nomogram for predicting survival in patients with second primary prostate cancer: a population study based on SEER database.
    Deng R; Zhou J; Qiu J; Cai L; Gong K
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11791-11806. PubMed ID: 37405473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of Prognostic Nomograms for Periampullary Neuroendocrine Neoplasms: A SEER Database Analysis.
    Chen J; Chen Q; Deng Y; Jiang Y; Huang Z; Zhou J; Zhao H; Cai J
    Curr Oncol; 2022 Dec; 30(1):344-357. PubMed ID: 36661677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
    Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
    Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms.
    Sun S; Wang W; He C
    Med Sci Monit; 2020 Jun; 26():e922613. PubMed ID: 32564052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
    Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
    Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based study.
    Ding X; Tian S; Hu J; Wang G; Yu X; Fu D; Yuan Y; Wang L; Wang Z
    Int J Colorectal Dis; 2021 Sep; 36(9):1915-1927. PubMed ID: 34061225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.